Richard Stone, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Revumenib in Combination With 7+3 + Midostaurin in AML (NCT06313437) | Richard Stone, MD | 2024-12-06 |
| RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS (NCT00819546) | Richard Stone, MD | 2009-01-01 |
Track Richard Stone, MD automatically
Every clearance here is in the API, with alerts when new ones post.